openPR Logo
Press release

Global Liver Cirrhosis Drugs Market is on the rise with Top Players Like: Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc.,  Dova Pharmaceuticals, GlaxoSmithKline Plc, Regeneron Pharmaceuticals, Mylan N.V

01-14-2020 03:39 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Liver Cirrhosis Drugs Market

Global Liver Cirrhosis Drugs Market

Global Liver Cirrhosis Drugs Market By Site of origin Type (Hepatitis C-related Cirrhosis, Alcoholic Cirrhosis,  Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Others), By Stage Type (Compensated cirrhosis and Decompensated cirrhosis), By Therapy Type (Medication, Healthy Diet, Surgery, Weight loss, Liver Transplantation  and Others), By Mechanism of Cation Type (Diuretic, Ammonia reducer, Beta blocker, Antibiotics, and Antiviral drug), By Drug Type (Ursodeoxycholic acid, Obeticholic acid, Azathioprine, Colchicine, and Others) By Route of Administration (Oral, Intravenous and Others), By End- users (Hospitals, Homecare, Specialty Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends & Forecast to 2026

Market Analysis: Global Liver Cirrhosis Drug Market

Global liver cirrhosis drugs market is rise gradually to an estimated value of USD 66.01 Billion by 2026 registering a CAGR of 10.5% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients.

 Get Sample Report + All Related Graphs & Charts @

Key Market Players: Global Liver Cirrhosis Drug Market

Few of the major competitors currently working in the global liver cirrhosis drug market are, Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc.,  Dova Pharmaceuticals, GlaxoSmithKline Plc, Regeneron Pharmaceuticals, Mylan N.V, Sanofi S.A,  Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd, Boehringer Ingelheim International GmbH, Sunovion Pharmaceuticals Inc., Merck & Co., Inc., Eli Lilly and Company, AbbVie Inc and among others.

Competitive Analysis: Global Liver Cirrhosis Drug Market

Global liver cirrhosis drugs market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of liver cirrhosis drugs market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Definition: Global Liver Cirrhosis Drug Market

Liver Cirrhosis is chronic injury to the liver which results in damage or liver might stop functioning due to chronic consumption of alcohol products, long term liver infection, defects in immune system and obesity etc. Liver cirrhosis develops slowly and it takes many years to develop. The patient with liver cirrhosis disease experience tiredness or unwell, loss of appetite, abdominal pain, white nail, dark urine and disturbed sleep pattern.

According to the survey report published BMJ Publishing Group Ltd, it is identified that from the year 1999 to 2016 in the United States the annual cirrhosis dead rate is increases by 65% to over 34174. The increase in prevalence of liver diseases, chronic consumption of alcohol and adoption of unhealthy diet are the factors contributing to rise in liver cirrhosis drugs market.

Grab Your Report at an Impressive 30% Discount! Please click Here @

Key Developments in the Market:

In May 2018, Dova Pharmaceuticals received the FDA approval Doptelet (avatrombopag), which previously received priority review for the treatment of the thrombocytopenia in adult patients with chronic liver disease (CLD). Doptelet is thrombopoietin receptor agonists which regulates the normal platelet production.
In May 2016, Intercept Pharmaceuticals, Inc. received FDA accelerated approval for Ocaliva alone or, in combination with ursodeoxycholic acid for patient who are unable to tolerate ursodeoxycholic acid for the treatment of primary biliary cholangitis (PBC).

Market Drivers

Increase in prevalence rate of Liver Cirrhosis Disease
Exposure to certain toxin or change in environment may increase the Liver Cirrhosis disease.
Chronic consumption of tobacco smoke and alcohol.
Patient who have experienced a long term long-term Hepatitis B or Hepatitis C infection.
Patient who are clinically over- weight and have fatty liver.
Rising awareness about treatment and technological advancement is driving the growth of market.
Increase in the rate of R&D initiatives is driving Liver Cirrhosis disease drug

Market Restraints

Effective treatment is either unavailable or unaffordable.
Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market.
Lack of awareness among the patient and physician about Liver Cirrhosis disease

Get Free Detailed TOC @

Segmentation: Global Liver Cirrhosis Drug Market

By Site of Origin Type

Hepatitis C-related Cirrhosis
Alcoholic Cirrhosis
Primary Sclerosing Cholangitis
Primary Biliary Cirrhosis

By Stage Type

Compensated cirrhosis
Decompensated cirrhosis

By Drug Type

Ursodeoxycholic acid
Obeticholic acid

By Therapy

Healthy Diet
Weight loss

By Route of administration


By End users

Specialty Clinics

Reasons to Purchase this Report

Current and future of global liver cirrhosis drugs market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at country level

All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Data Bridge Market Research

US: +1 888 387 2818   

UK: +44 208 089 1725   

Hong Kong: +852 8192 7475


About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.            

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Liver Cirrhosis Drugs Market is on the rise with Top Players Like: Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc.,  Dova Pharmaceuticals, GlaxoSmithKline Plc, Regeneron Pharmaceuticals, Mylan N.V here

News-ID: 1896111 • Views: 598

More Releases from Data Bridge Market Research

Global IV Equipment Market Challenges On Upcoming Trends 2027 | BD, Ascor SA, Mo …
CAGR levels are developing and the Global IV Equipment Market changing day by day. The Global IV Equipment Market report includes all the market definitions, classifications, segments, programs, engagements and marketplace trends the user needs to understand so one can be successful inside the Global IV Equipment Marketplace. This report ambitions to observe the trends of Global IV Equipment Marketplace together with its marketplace development, development, position and others which are
Global Rx Dermatology Topical Drug Delivery Market Research Report 2019-2026 Gro …
The key players of the Rx Dermatology Topical Drug Delivery market are making moves like product launches, joint ventures, developments, merges and accusations which is affecting the Additive Manufacturing market and Industry as a whole and also affecting the sales, import, export, revenue and CAGR values. Rx Dermatology Topical Drug Delivery market report also provides with the information about company profile, product specifications, capacity, production value, and market shares for each
eClinical Solutions Market has been driven by Increasing Adoption of Clinical Tr …
eClinical solutions are comprised of electronic health record, electronic consent forms, integrating eTechnologies, electronic data capture and clinical data management systems. eClinical solutions are helping researchers in end-to-end clinical research process providing solution, through proper management of lengthy clinical research process. Advancement in technology and government initiatives raises the market of eClinical solutions. It helps the clinical research organizations with regulatory document management, team collaboration and management of supply chains,
Global Liquid Biopsy Market rising CAGR of 23.80%, Increasing Demand, Developmen …
Liquid Biopsy is minimally invasive technology which does not require costly invasive procedures. It enables the doctors to access various diseases and make a decision through blood sample of the patient. It is mainly used for monitoring and diagnostic purpose. Various doctors use it to test the cancer in the blood cells of the patient. It only requires 5 milliliters of blood which means they are much easier to tolerate

All 5 Releases

More Releases for Cirrhosis

Liver Cirrhosis Market Report 2018: Segmentation by Product (Alcoholic Cirrhosis …
Global Liver Cirrhosis market research report provides company profile for Bristol-Myers Squibb, Conatus Pharmaceuticals, Gwo Xi Stem Cell Applied Technology, Instituto Grifols, Intercept Pharmaceuticals, F Hoffman La-Roche, GlaxoSmithKline, Gilead Sciences, Johnson & Johnson, Merck and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate,
Recent Study Explores Liver Cirrhosis Industry Pipeline Review, H2 2017
Overview Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse. The scar tissue damages the normal structure of the liver which affects the normal flow of blood through the liver. Symptoms include loss of appetite, itchy skin, weight loss, tiredness and weakness and nausea. Treatment includes liver transplant surgery.  Click here for sample report @ Report Highlights The Pharmaceutical and
Biliary Cirrhosis Market Analysis and Forecast Upto 2020
The research report elaborates the different types of tests that are available across the globe for diagnosing biliary cirrhosis. The report also includes the innovative treatments that are made available for biliary cirrhosis patients. Report Overview @ Apart from that, the research report covers all the vital aspects of biliary cirrhosis including detailed and accurate information of the market. The report has also provided graphical representations along with the
Liver Cirrhosis Therapeutics Pipeline Analysis- Clinical Trials & Results, Desig …
Liver cirrhosis is a condition in which liver deteriorates and gradually ceases the liver function. The healthy tissues of the liver are replaced by the scar tissues that block the blood flow in the liver. The main functions of the liver include removal of waste products, making new proteins, producing bile, and processing of the nutrients. The building up of scar tissue gets worse throughout the period and causes chronic
Liver Cirrhosis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Liver Cirrhosis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cirrhosis - Pipeline Review, H2 2017, provides an overview of the Liver Cirrhosis (Gastrointestinal) pipeline landscape. Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and
Liver Cirrhosis-Market Insights, Epidemiology and Market Forecast-2025
"The Report Liver Cirrhosis-Market Insights, Epidemiology and Market Forecast-2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -" ​DelveInsights Liver Cirrhosis-Market Insights, Epidemiology and Market Forecast-Market Insights, Epidemiology and Market Forecast-2025 report provides an overview of the disease and in depth research related to Liver Cirrhosis-Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for